Results 171 to 180 of about 16,081 (221)

A nomogram-based clinical prediction model for adverse clinical outcomes in non-HIV Pneumocystis jirovecii pneumonia patients. [PDF]

BMC Pulm Med
Wang D, Guan L, Yin Q, Hou X, Zhan X, Tong Z.   +5 more
europepmc   +1 more source

Development and validation of supervised machine learning multivariable prediction models for the diagnosis of Pneumocystis jirovecii pneumonia using nasopharyngeal swab PCR in adults in a low-HIV prevalence setting. [PDF]

Int Health
Chew R, Woods ML, Paterson DL.
europepmc   +1 more source

Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release Assays. [PDF]

Diagnostics (Basel)
Neumann FAO, Müller M, Mattert G, Liebig S, Herbst V, Zapf D, Kiderlen TR, Linke C, Arp F, Deckert PM, Lüth S, Schwarzlose-Schwarck S, Dammermann W, Reinwald M.   +13 more
europepmc   +1 more source

Pneumocystis Jirovecii Pneumonia in Two Immunosuppressed Non-HIV Infected Patients: A Clinical and Therapeutic Analysis. [PDF]

Infect Drug Resist
Li W, Hua M, Guo J, Jia W.
europepmc   +1 more source

The effectiveness of high-dose adjunctive corticosteroid therapy in HIV-negative patients with <i>Pneumocystis jirovecii</i> pneumonia. [PDF]

J Thorac Dis
Wang L, Tan Z, Fan Y, Wang Z, Wang Z, Pan H, Zhang G.   +6 more
europepmc   +1 more source

Prognostic Significance of BALF Neutrophil Percentage and Hypoxemia in Non-HIV <i>Pneumocystis jirovecii</i> Pneumonia: A Retrospective Cohort Study. [PDF]

Infect Drug Resist
Li Y, Li X, Zhao F, Zhou Q, Sun Y.
europepmc   +1 more source

Retroperitoneal haematoma with pneumocystis jirovecii pneumonia

, 2019
openaire   +1 more source